Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease

• मुख्य लेखकों: V. I. Ignatyeva (लेखक), S. V. Moiseev (लेखक), N. M. Bulanov (लेखक), E. A. Karovajkina (लेखक), A S. Moiseev (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: IRBIS LLC, 2019-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Fabry disease (FD) is a severe lysosome storage disease caused by congenital deficiency of the enzyme α-galactosidase A and characterized by the risk of renal failure combined with cardiovascular and CNS complications. According to the currently available information, the early start of enzyme repla...